908 Devices Shares Rise as FY Revenue Is Projected to Hit High End of Outlook

Dow Jones
Jan 20
 

By Connor Hart

 

Shares of 908 Devices opened higher after the company said it expects full-year revenue to come in at the high end of its previously guided range.

The stock was trading hands at $6.28 in morning trading Tuesday, up 15%. Shares have more than doubled over the past year.

The maker of chemical-analysis devices before the bell said it expects revenue of about $56 million in 2025, marking a 17% increase from the previous year. It had previously forecast full-year revenue of $54 million to $56 million. Analysts are expecting $54.8 million, according to FactSet.

For the fourth quarter, 908 Devices expects revenue to climb about 20% year over year, to $17.2 million. The company attributed the gain to continued outperformance in the U.S., ramping international adoption of products, and sales to federal and defense customers.

"In 2025, we transformed our company into a stronger, simpler and more profitable financial model focused on frontline chemical detection," Chief Executive Kevin Knopp said.

908 Devices said it plans to report its full fourth-quarter and full-year results later this quarter, at which time it will provide its 2026 outlook.

 

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

January 20, 2026 09:53 ET (14:53 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10